Search Results

Your search for Alexander B. Pine, MD, PhD, and Alfred I. Lee, MD, PhD matches 2 pages

Showing 1 - 2

By Alexander B. Pine, MD, PhD, and Alfred I. Lee, MD / Wednesday, February 6, 2019 6:07 PM

Letter to the Editor: Survey on DOACs in Cancer-Related Venous Thromboembolism

This letter is a follow-up to a report published previously in The ASCO Post. Recent trials report comparable or improved efficacy of direct-acting oral coagulants (DOACs) over low–molecular-weight heparins (LMWH) in the treatment of cancer-related VTE (cVTE) at the expense of increased...

symptom management

By Alexander B. Pine, MD, PhD, and Alfred I. Lee, MD, PhD / December 25, 2018

Clinician Survey to Explore Direct-Acting Oral Anticoagulants vs Low–Molecular-Weight Heparin in Cancer-Related VTE

Injectable low–molecular-weight heparin has long been considered the standard of care for treatment of venous thromboembolism (VTE) in patients with cancer. However, low–molecular-weight heparin is costly and often disliked by patients due to injection-related discomfort and bruising....

Apr

Today In Oncology

Search Results

Your search for Alexander B. Pine, MD, PhD, and Alfred I. Lee, MD, PhD matches 2 pages

Letter to the Editor: Survey on DOACs in Cancer-Related Venous Thromboembolism

Clinician Survey to Explore Direct-Acting Oral Anticoagulants vs Low–Molecular-Weight Heparin in Cancer-Related VTE

Comparative Effectiveness of Acupuncture vs Massage for Relieving Pain in Patients With Advanced Cancer

Risk of Second Primary Breast Cancer in Young Breast Cancer Survivors

Adagrasib Plus Cetuximab in KRAS G12C–Mutated Colorectal Cancer

Improving Early Detection of Pancreatic Cancer in High-Risk Patients

Survival Rates in Patients With Cancer and Intellectual and Developmental Disabilities